Search Results - s.+paul+bajaj

1 Results Sort By:
Engineered TFPI-2 KD1 Peptide Therapeutics for Control of Excessive Bleeding (UCLA Case Nos. 2019-981, 2012-611, 2006-064)
UCLA researchers in the School of Medicine have developed engineered peptide therapeutics based on the tissue factor pathway inhibitor-2 (TFPI-2) Kunitz domain 1 (KD1), which can serve as potent inhibitors of fibrinolysis to control excessive bleeding. BACKGROUND: Excessive bleeding remains a major unmet need in hematology, surgery, trauma care, and...
Published: 6/26/2026   |   Updated: 6/26/2026   |   Inventor(s): S. Paul Bajaj
Keywords(s): Hematology, Therapeutics & Vaccines
Category(s): Therapeutics > Hematology